$NKLA
Nikola Corp

2022 Q4 Form 10-Q Financial Statement

#000173128922000256 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $6.563M $24.24M
YoY Change
Cost Of Revenue $52.33M $54.41M
YoY Change
Gross Profit -$45.76M -$30.17M
YoY Change
Gross Profit Margin -697.27% -124.45%
Selling, General & Admin $80.24M $132.9M
YoY Change 12.15% -31.13%
% of Gross Profit
Research & Development $69.42M $66.68M
YoY Change -23.85% -15.48%
% of Gross Profit
Depreciation & Amortization $6.828M $3.900M
YoY Change 200.53% 77.27%
% of Gross Profit
Operating Expenses $149.7M $199.5M
YoY Change -8.02% -26.59%
Operating Profit -$195.4M -$229.7M
YoY Change 20.1% -15.49%
Interest Expense -$6.986M -$7.735M
YoY Change 2566.41% 6455.08%
% of Operating Profit
Other Income/Expense, Net -$5.065M $2.617M
YoY Change -224.39% 147.59%
Pretax Income -$207.5M -$234.2M
YoY Change 30.57% -12.07%
Income Tax $3.000K $1.000K
% Of Pretax Income
Net Earnings -$222.1M -$236.2M
YoY Change 39.3% -11.71%
Net Earnings / Revenue -3383.61% -974.52%
Basic Earnings Per Share -$0.54
Diluted Earnings Per Share -$0.46 -$0.54
COMMON SHARES
Basic Shares Outstanding 478.9M shares 433.5M shares
Diluted Shares Outstanding 438.4M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $233.4M $315.7M
YoY Change -53.06% -46.21%
Cash & Equivalents $233.4M $315.7M
Short-Term Investments
Other Short-Term Assets $20.64M $23.66M
YoY Change 29.87% 22.15%
Inventory $123.2M $81.07M
Prepaid Expenses $11.75M
Receivables $31.90M $37.66M
Other Receivables $11.55M $11.73M
Total Short-Term Assets $436.9M $486.9M
YoY Change -16.73% -20.18%
LONG-TERM ASSETS
Property, Plant & Equipment $437.0M $365.0M
YoY Change 78.82% 81.93%
Goodwill $6.688M $5.238M
YoY Change 27.68% 0.0%
Intangibles $93.09M $93.61M
YoY Change -4.21% -3.68%
Long-Term Investments $72.82M $76.51M
YoY Change 17.87% 22.66%
Other Assets $32.06M $7.484M
YoY Change 722.77%
Total Long-Term Assets $799.7M $672.5M
YoY Change 71.95% 72.21%
TOTAL ASSETS
Total Short-Term Assets $436.9M $486.9M
Total Long-Term Assets $799.7M $672.5M
Total Assets $1.237B $1.159B
YoY Change 24.94% 15.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $117.9M $92.51M
YoY Change 35.56% 61.59%
Accrued Expenses $230.8M $176.1M
YoY Change 141.03% 3.06%
Deferred Revenue
YoY Change
Short-Term Debt $1.999M $4.002M
YoY Change
Long-Term Debt Due $61.12M $10.36M
YoY Change 43553.57%
Total Short-Term Liabilities $383.6M $277.6M
YoY Change 112.39% 9.67%
LONG-TERM LIABILITIES
Long-Term Debt $291.6M $283.3M
YoY Change 1064.32% 66081.78%
Other Long-Term Liabilities $6.303M $28.35M
YoY Change -92.5% -18.38%
Total Long-Term Liabilities $6.303M $28.35M
YoY Change -92.5% -18.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $383.6M $277.6M
Total Long-Term Liabilities $6.303M $28.35M
Total Liabilities $710.2M $595.4M
YoY Change 139.73% 103.42%
SHAREHOLDERS EQUITY
Retained Earnings -$2.035B -$1.813B
YoY Change 62.71% 66.13%
Common Stock $51.00K $46.00K
YoY Change 24.39% 15.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $526.5M $564.0M
YoY Change
Total Liabilities & Shareholders Equity $1.237B $1.159B
YoY Change 24.94% 15.88%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$222.1M -$236.2M
YoY Change 39.3% -11.71%
Depreciation, Depletion And Amortization $6.828M $3.900M
YoY Change 200.53% 77.27%
Cash From Operating Activities -$145.2M -$157.6M
YoY Change 29.93% 127.17%
INVESTING ACTIVITIES
Capital Expenditures $52.29M -$51.12M
YoY Change -179.72% 4.55%
Acquisitions
YoY Change
Other Investing Activities $984.0K -$28.48M
YoY Change -128.84%
Cash From Investing Activities -$51.31M -$79.60M
YoY Change -25.64% 62.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 115.7M 111.8M
YoY Change -0.27% 54.06%
NET CHANGE
Cash From Operating Activities -145.2M -157.6M
Cash From Investing Activities -51.31M -79.60M
Cash From Financing Activities 115.7M 111.8M
Net Change In Cash -80.83M -125.4M
YoY Change 24.84% 174.42%
FREE CASH FLOW
Cash From Operating Activities -$145.2M -$157.6M
Capital Expenditures $52.29M -$51.12M
Free Cash Flow -$197.5M -$106.5M
YoY Change 327.61% 419.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001731289
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38495
dei Entity Registrant Name
EntityRegistrantName
Nikola Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-4151153
dei Entity Address Address Line1
EntityAddressAddressLine1
4141 E Broadway Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Phoenix
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85040
dei City Area Code
CityAreaCode
480
dei Local Phone Number
LocalPhoneNumber
666-1038
dei Security12b Title
Security12bTitle
Common stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
NKLA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
478851041 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
315731000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
497241000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
600000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37662000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
81069000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
11597000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51858000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15891000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
486920000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
524729000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
87459000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
25000000 usd
CY2022Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
37161000 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
27620000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
365049000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
244377000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
93609000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
97181000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
76505000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
61778000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
5238000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
5238000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7484000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3896000 usd
CY2022Q3 us-gaap Assets
Assets
1159425000 usd
CY2021Q4 us-gaap Assets
Assets
989819000 usd
CY2022Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
92511000 usd
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
86982000 usd
CY2022Q3 nkla Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
170707000 usd
CY2021Q4 nkla Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
93487000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
14357000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
140000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
277575000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
180609000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
283258000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
25047000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5410000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2263000 usd
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
791000 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
4284000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28349000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
84033000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
13000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
595396000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
296247000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
150000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
150000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
455205699 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
455205699 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
413340550 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
413340550 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
46000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
41000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2379191000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1944341000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1812784000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1250612000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2424000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-198000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
564029000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
693572000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1159425000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
989819000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24241000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44262000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
54410000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
103257000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-30169000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2021Q2 nkla Sale Of Stock Purchase Period
SaleOfStockPurchasePeriod
P36M
us-gaap Gross Profit
GrossProfit
-58995000 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
66683000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
78896000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
204346000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
201785000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
132865000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
192929000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
289916000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
329028000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
199548000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
271825000 usd
us-gaap Operating Expenses
OperatingExpenses
494262000 usd
us-gaap Operating Expenses
OperatingExpenses
530813000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-229717000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-271825000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-553257000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-530813000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7735000 usd
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-118000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-10754000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-219000 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-586000 usd
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4467000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3493000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2907000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2617000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1057000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4423000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
174000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-234249000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-266419000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-556095000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-527951000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 usd
CY2022Q3 nkla Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax
-234250000 usd
CY2021Q3 nkla Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax
-266420000 usd
nkla Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax
-556098000 usd
nkla Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax
-527955000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1984000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1147000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6074000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3067000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-236234000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5959000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-267567000 usd
us-gaap Net Income Loss
NetIncomeLoss
-562172000 usd
us-gaap Net Income Loss
NetIncomeLoss
-531022000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.34
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.35
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
438416393 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
400219585 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
426382736 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
395691795 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
438416393 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
400230669 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
426382736 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
395860876 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-236234000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-267567000 usd
us-gaap Net Income Loss
NetIncomeLoss
-562172000 usd
us-gaap Net Income Loss
NetIncomeLoss
-531022000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1237000 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-123000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2226000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-358000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-237471000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-267690000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-564398000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-531380000 usd
CY2021Q2 nkla Issuance Of Stock For Commitment Shares
IssuanceOfStockForCommitmentShares
2600000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
599251000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1405000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
102845000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-236234000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1237000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
564029000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
693572000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1970000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
211214000 usd
us-gaap Net Income Loss
NetIncomeLoss
-562172000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2226000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
564029000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
844777000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
355000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2939000 usd
CY2021Q3 nkla Adjustments To Additional Paid In Capital Elimination Of Put Right
AdjustmentsToAdditionalPaidInCapitalEliminationOfPutRight
5532000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
49047000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-267567000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-123000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
707826000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
980141000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3981000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
5564000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
19139000 usd
nkla Adjustments To Additional Paid In Capital Elimination Of Put Right
AdjustmentsToAdditionalPaidInCapitalEliminationOfPutRight
5532000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
151983000 usd
us-gaap Net Income Loss
NetIncomeLoss
-531022000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-358000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
707826000 usd
us-gaap Net Income Loss
NetIncomeLoss
-562172000 usd
us-gaap Net Income Loss
NetIncomeLoss
-531022000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16472000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
211214000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
151983000 usd
nkla Non Cash In Kind Services
NonCashInKindServices
0 usd
nkla Non Cash In Kind Services
NonCashInKindServices
40230000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6074000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3067000 usd
nkla Fair Value Adjustment Of Warrants And Derivative Gain Loss On Derivative Net
FairValueAdjustmentOfWarrantsAndDerivativeGainLossOnDerivativeNet
94000 usd
nkla Fair Value Adjustment Of Warrants And Derivative Gain Loss On Derivative Net
FairValueAdjustmentOfWarrantsAndDerivativeGainLossOnDerivativeNet
3226000 usd
nkla Issuance Of Stock For Commitment Shares
IssuanceOfStockForCommitmentShares
0 usd
nkla Issuance Of Stock For Commitment Shares
IssuanceOfStockForCommitmentShares
5564000 usd
us-gaap Inventory Write Down
InventoryWriteDown
16617000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
8890000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-476000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1010000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
37662000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
97952000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3644000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
10371000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7090000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25128000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
147160000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-8356000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4705000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
912000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-416000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1605000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-655000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-431459000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-195369000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
118436000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
113680000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
23027000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
25000000 usd
nkla Payments For Issuance Of Senior Secured Debt And Prepaid Business Combination Consideration
PaymentsForIssuanceOfSeniorSecuredDebtAndPrepaidBusinessCombinationConsideration
21910000 usd
nkla Payments For Issuance Of Senior Secured Debt And Prepaid Business Combination Consideration
PaymentsForIssuanceOfSeniorSecuredDebtAndPrepaidBusinessCombinationConsideration
0 usd
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
6588000 usd
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
18000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
200000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-169943000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-138480000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1645000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4194000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
123672000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
72866000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
183504000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100512000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
54000000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
44007000 usd
us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
6637000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
28125000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
4100000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
2635000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
266000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
759000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
644000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
482951000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71557000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-118451000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-262292000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
522241000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
849278000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
403790000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
586986000 usd
us-gaap Interest Paid Net
InterestPaidNet
2643000 usd
us-gaap Interest Paid Net
InterestPaidNet
573000 usd
nkla Interest Received
InterestReceived
257000 usd
nkla Interest Received
InterestReceived
456000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
28912000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
21001000 usd
nkla Accrued Paid In Kind Interest
AccruedPaidInKindInterest
7284000 usd
nkla Accrued Paid In Kind Interest
AccruedPaidInKindInterest
0 usd
nkla Accrued Underwriting Commissions
AccruedUnderwritingCommissions
2513000 usd
nkla Accrued Underwriting Commissions
AccruedUnderwritingCommissions
0 usd
nkla Embedded Derivative Asset Bifurcated From Convertible Note
EmbeddedDerivativeAssetBifurcatedFromConvertibleNote
1500000 usd
nkla Embedded Derivative Asset Bifurcated From Convertible Note
EmbeddedDerivativeAssetBifurcatedFromConvertibleNote
0 usd
nkla Stock Option Proceeds Receivable
StockOptionProceedsReceivable
325000 usd
nkla Stock Option Proceeds Receivable
StockOptionProceedsReceivable
0 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
311000 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 usd
nkla Accrued Deferred Issuance Costs
AccruedDeferredIssuanceCosts
0 usd
nkla Accrued Deferred Issuance Costs
AccruedDeferredIssuanceCosts
439000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
698000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
11125000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Stock Issued1
StockIssued1
5564000 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
0 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
32376000 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
47181000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
315700000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
497200000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
88100000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
25000000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
315731000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
497241000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
586986000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
600000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
87459000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
25000000 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
403790000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
522241000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
586986000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Asset
EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset
500000 usd
CY2022Q3 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
10081000 usd
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
791000 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
4284000 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
4189000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
200000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
200000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-213000 usd
CY2022Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P2Y8M4D
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P3Y5M1D
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2203000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
0 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
0 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2611000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
4601000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4401000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4401000 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
63398000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7344000 usd
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5547000 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4253000 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10935000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0 usd
CY2022Q3 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
1189000 usd
CY2021Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
0 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
81069000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
11597000 usd
CY2022Q3 nkla Prepaid Business Combination Consideration Current
PrepaidBusinessCombinationConsiderationCurrent
11910000 usd
CY2021Q4 nkla Prepaid Business Combination Consideration Current
PrepaidBusinessCombinationConsiderationCurrent
0 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11750000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5116000 usd
CY2022Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
10081000 usd
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
0 usd
CY2022Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
7206000 usd
CY2021Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
2717000 usd
CY2022Q3 nkla Sale Agreement Receivable
SaleAgreementReceivable
4528000 usd
CY2021Q4 nkla Sale Agreement Receivable
SaleAgreementReceivable
0 usd
CY2022Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4204000 usd
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
5615000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
2179000 usd
CY2021Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
2443000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51858000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15891000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2400000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022Q3 nkla Accrued Purchases Of Property And Equipment Current
AccruedPurchasesOfPropertyAndEquipmentCurrent
6620000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
1338000 usd
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
646000 usd
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
391991000 usd
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
260884000 usd
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
26942000 usd
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
16507000 usd
CY2022Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
365049000 usd
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
244377000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
3900000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
2200000 usd
us-gaap Depreciation
Depreciation
10500000 usd
us-gaap Depreciation
Depreciation
5900000 usd
CY2021Q4 nkla Accrued Purchases Of Property And Equipment Current
AccruedPurchasesOfPropertyAndEquipmentCurrent
2817000 usd
CY2022Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
70000000 usd
CY2021Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
50000000 usd
CY2022Q3 nkla Accrued Purchase Of Intangible Asset
AccruedPurchaseOfIntangibleAsset
29398000 usd
CY2021Q4 nkla Accrued Purchase Of Intangible Asset
AccruedPurchaseOfIntangibleAsset
11344000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20318000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8699000 usd
CY2022Q3 nkla Inventory Received Not Yet Invoiced
InventoryReceivedNotYetInvoiced
19017000 usd
CY2021Q4 nkla Inventory Received Not Yet Invoiced
InventoryReceivedNotYetInvoiced
8253000 usd
CY2022Q3 nkla Accrued Legal Liabilities Current
AccruedLegalLiabilitiesCurrent
17784000 usd
CY2021Q4 nkla Accrued Legal Liabilities Current
AccruedLegalLiabilitiesCurrent
5664000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7570000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2521000 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4189000 usd
CY2022Q3 nkla Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
170707000 usd
CY2021Q4 nkla Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
93487000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
76505000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
61778000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1984000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1147000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6074000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3067000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2900000 usd
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
800000 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
4300000 usd
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
355000 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
140000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
14357000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
140000 usd
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
619000 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
408000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
283258000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
25047000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2022Q2 nkla Debt Instrument Covenant Secured Debt Limit
DebtInstrumentCovenantSecuredDebtLimit
500000000 usd
CY2022Q2 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P20Y
CY2022Q2 nkla Lessee Finance Lease Number Of Options To Extend
LesseeFinanceLeaseNumberOfOptionsToExtend
4 extension_option
CY2022Q2 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P7Y
CY2022Q2 nkla Lessee Finance Lease Number Of Extension Options Reasonably Certain Of Being Exercised
LesseeFinanceLeaseNumberOfExtensionOptionsReasonablyCertainOfBeingExercised
1 extension_option
CY2022Q3 nkla Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
950000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
150000000 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
760915 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
nkla Class Of Warrant Or Right Period Following Business Combination
ClassOfWarrantOrRightPeriodFollowingBusinessCombination
P30D
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-600000 usd
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4500000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3500000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
28996160 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.28
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M13D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1581791 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
29281 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.39
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27385088 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.28
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M2D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
27275672 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.27
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y29D
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
102845000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49047000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
211214000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
151983000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
184000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
178629000 usd
CY2020Q3 nkla Number Of Class Action Lawsuits
NumberOfClassActionLawsuits
6 lawsuit
CY2022Q1 nkla Loss Contingency Period To File Opposition
LossContingencyPeriodToFileOpposition
P30D
CY2022Q1 nkla Loss Contingency Defendants Period Due To Reply Plaintiffs
LossContingencyDefendantsPeriodDueToReplyPlaintiffs
P30D
CY2020Q3 nkla Number Of Derivative Actions
NumberOfDerivativeActions
2 derivative_action
CY2020Q4 nkla Period Of Derivative Action
PeriodOfDerivativeAction
P30D
CY2021Q1 nkla Period Of Derivative Action
PeriodOfDerivativeAction
P30D
CY2022Q1 nkla Loss Contingency Period To File Operative Complaint
LossContingencyPeriodToFileOperativeComplaint
P14D
CY2022Q2 nkla Loss Contingency Defendants To Submit The Status Report Due Period
LossContingencyDefendantsToSubmitTheStatusReportDuePeriod
P3D
CY2022Q3 nkla Lessee Operating Lease Lease Not Yet Commenced Undiscounted Lease Payments
LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedLeasePayments
13300000 usd
CY2022Q3 us-gaap Purchase Obligation
PurchaseObligation
14300000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-236234000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-267567000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-562172000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-531022000 usd
CY2022Q3 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2021Q3 us-gaap Dilutive Securities
DilutiveSecurities
-4467000 usd
us-gaap Dilutive Securities
DilutiveSecurities
0 usd
us-gaap Dilutive Securities
DilutiveSecurities
-2907000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-236234000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-272034000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-562172000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-533929000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
438416393 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
400219585 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
426382736 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
395691795 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
11084 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
169081 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
438416393 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
400230669 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
426382736 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
395860876 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.34
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.35
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
74929848 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
53619079 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
74929848 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
53619079 shares

Files In Submission

Name View Source Status
0001731289-22-000256-index-headers.html Edgar Link pending
0001731289-22-000256-index.html Edgar Link pending
0001731289-22-000256.txt Edgar Link pending
0001731289-22-000256-xbrl.zip Edgar Link pending
exhibit311q322.htm Edgar Link pending
exhibit312q322.htm Edgar Link pending
exhibit321q322.htm Edgar Link pending
exhibit322q322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
firstamendmenttoivecotechn.htm Edgar Link pending
firstamendmenttonikolatech.htm Edgar Link pending
firstamendmenttos-wayplatf.htm Edgar Link pending
firstamendmenttotechnicala.htm Edgar Link pending
MetaLinks.json Edgar Link pending
nkla-20220930.htm Edgar Link pending
nkla-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
nkla-20220930_def.xml Edgar Link unprocessable
nkla-20220930_lab.xml Edgar Link unprocessable
nkla-20220930_pre.xml Edgar Link unprocessable
nkla-20220930_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nkla-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable